Specialty vaccine company Valneva SE and Pfizer Inc. announced a collaboration to develop VLA15, Valneva’s Lyme disease vaccine candidate, which is currently in Phase 2 clinical studies.
Search Results for: Lyme disease
From LDA President Pat Smith’s Blog: May is Lyme Disease Awareness Month, a time to remind ourselves that Lyme is a disease that has been neglected, minimized, and ridiculed over decades and still continues to be. We all need to redouble our efforts to get an accurate test and to get patients properly treated and treated with dignity. The continued arbitrary…
Dr. Richard Horowitz, Dr. Phyllis Freeman, and James Bruzzese have published their case report, “Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases” evaluating two patients with Lyme disease and COVID-19 in Respiratory Medicine Case Reports.
The Lyme Disease Association (LDA) and Columbia University jointly announce we have made a thoughtful but reluctant decision to postpone our annual fall 2020 CME Lyme & Other Tick-Borne Diseases […]
Rep. Chris Smith Rep. Collin Peterson ISSUE At this time the Lyme Disease Association, Inc. is asking you to contact your Congress Member to ask him/her to sign on to […]
Lyme Disease Association Inc.Board of Directors 2023 Patricia V. Smith, BA President Bio Publications Richard H. Smith, BA Executive Vice President, Treasurer Bio Corey Lakin, AB 2nd Vice President, Technical […]